Physician profile
Ruchir Patel
NPI 1245506625
$5,278.65
in general payments reported to CMS, 2019-2025
26 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,591 · 2020: $49.22 · 2021: $181 · 2022: $283 · 2023: $327 · 2024: $697 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,120 · Travel and Lodging: $53.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,120.49 |
| Travel and Lodging | $53.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $979.73 | 2019-2020 | |
| Edwards Lifesciences Corporation | $731.22 | 2019-2025 | Pascal |
| Inspire Medical Systems, INC. | $598.79 | 2025 | Inspire |
| Medtronic, INC. | $472.60 | 2021-2025 | Corevalve Evolut R, Inceptiv |
| Boston Scientific Corporation | $468.23 | 2019-2025 | Watchman Flx, Watchman, Bodyguardian |
| Cardiva Medical, INC. | $340.83 | 2019 | |
| Abiomed | $237.60 | 2022-2023 | Impella |
| Cardiovascular Systems INC. | $230.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.83 | 2019-2025 | Lifevest |
| Abbott Laboratories | $168.60 | 2021-2025 | Freestyle Libre 3 |
| Biotronik INC. | $160.83 | 2023-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Imperative Care, INC | $145.16 | 2025 | Symphony Catheter |
| Pfizer INC. | $100.41 | 2024-2025 | |
| Terumo Medical Corporation | $94.65 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $83.57 | 2019-2025 | Camzyos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $45.88 | 2024 | |
| Corcept Therapeutics | $40.92 | 2024 | Korlym |
| Lilly USA, LLC | $32.95 | 2022-2025 | Jardiance |
| Amgen INC. | $28.26 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $25.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.30 | 2024 | |
| Abbvie INC. | $22.86 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.29 | 2021 | |
| Acella Pharmaceuticals, LLC | $16.41 | 2025 | NP Thyroid 60 |
| Pulmonx Corporation | $15.61 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Cook Medical LLC | $14.31 | 2023 | Cook Celect |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruchir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.